The Center for Advanced Heart Failure and Mechanical Cardiology Support, the only such center in the region, is an area of special care at WVU Medicine. It provides IV inotropic therapy to stable outpatients with advanced heart failure, with a goal of improving functional level and avoiding hospitalization. The center is an important resource for the state, reducing the number of emergency room visits and lowering health costs for heart patients. Many patients receive treatment through medication. The treatments are especially useful for patients who are at the maximum dosage of other heart drugs, people awaiting a heart transplant, or people who have a heart muscle disease. The treatment also helps patients breathe more easily.
Quick Facts about the WVU Medicine Advanced Heart Failure Program
Provides IV inotropic therapy to stable outpatients with advanced heart failure, with a goal of improving functional level and avoiding hospitalization
One of 16 national sites of excellence to offer the CardioMEMS™ HF system, the first and only FDA-approved heart failure (HF) monitoring system proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class Ill patients
Recognized for Excellence in Heart Failure
The WVU Heart and Vascular Institute has received theGet With The Guidelines®-Heart Failure Gold Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American College of Cardiology Foundation’s secondary prevention guidelines for patients with heart failure. This includes meeting quality achievement measures for the diagnosis and treatment of heart failure patients, including evaluation of the patient, proper use of medications, and aggressive risk-reduction therapies. Before patients are discharged, they also receive education on managing their heart failure and overall health, a scheduled follow-up visit, and other care transition interventions.
CardioMEMS HF System
It is estimated that patients who monitor their congestive heart failure with the CardioMEMS system may reduce their risk for sudden hospital readmission by almost 37 percent. We are designated as one of 16 national sites of excellence by the device manufacturer, and we are the only site in West Virginia currently offering this procedure. WVU Heart and Vascular Institute physicians are proud to be able to offer this technology to our patients.
Another option for the intractable angina patient who fails to respond to conventional treatment is a non-invasive technique called enhanced external counterpulsation (EECP). This therapy involves placing blood pressure cuffs on the lower extremities to force blood from the heart into the vessels.
Ensuring Jaime’s Ability to Enjoy Being a Mom
Congestive heart failure patient Jaime explains how Dr. George Sokos of The WVU Heart and Vascular Institute saved her life.
Associate Professor, Assistant Director of Pulmonary Hypertension and Assistant Director of Mechanical Circulatory Support in the Advanced Heart Failure Program WVU Heart and Vascular Institute, J.W. Ruby Memorial Hospital
Director, Advanced Heart Failure, Heart and Vascular Institute - Morgantown; Director, Advanced Heart Failure; Associate Professor of Medicine WVU Heart and Vascular Institute, J.W. Ruby Memorial Hospital